Image Provided By Unsplash
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Pressure BioSciences, Inc. (OTCQB: PBIO) is the biotech pioneer behind a range of pressure-based technology platforms that have been helping researchers and manufacturers across pharmaceuticals, nutraceuticals, cosmetics, agrochem, and many other industries develop more effective, reliable, and stable products for consumers.
Hundreds of research and manufacturing labs worldwide are already using the technology, which relies on precision-controlled pressure to manipulate substances ranging from oils to proteins and other biomolecules.
While many high value medical sciences companies — like Pfizer (NYSE: PFE), Merck (NYSE: MRK), and AstraZeneca (NASDAQ: AZN) — are always searching for cutting-edge mechanisms like this, Pressure BioSciences, Inc. (PBI) jumped the innovation gap and has made a significant contribution to the sector. The company says that it now finds itself amid a budding market for high-pressure equipment that is forecasted to exceed $1.2 billion by 2030.
PBI’s portfolio includes 3 patented pressure-based technology platforms: the Pressure Cycling Technology (PCT) platform, the BaroFold platform, and the Ultra Shear Technology™ (UST™) platform. Here’s how each works, how they’re revolutionizing the industries they’re used in, and why they offer the potential to completely transform multi-billion-dollar global markets.
Pressure Cycling Technology Helps Researchers Process Samples Faster, More Reliably
The PCT platform alternates cycles of ambient and ultra-high pressure levels to exquisitely control biomolecular reactions — a key step in the design, development, and quality control of drugs as well as in biomarker discovery, forensics, and countless other applications.
Its patented high pressure system can apply pressure up to 45,000 pounds per square inch (PSI) to the biological samples (e.g., cells, pathogens) and compounds (e.g., enzymes, hormones) researchers put into special pressure resistant tubes that are then placed into its pressure chamber. As a result, those researchers can avoid time-consuming, inefficient, and sometimes destructive alternatives like using heat or chemicals to manipulate the samples they’re working with at ambient temperature and pressure.
That same high-pressure system can …